Malaria Diagnostics Market - Global Industry Trends and Forecast Analysis 201917 Nov 2015
Malaria is an infectious disease caused by plasmodium parasites that is transmitted from female anopheles mosquito.WHO stated that, malaria is one of the top public health challenge,globally. There are four species of malarial parasite that cause the disease namely,plasmodium vivax, plasmodium malariae, plasmodium ovale, and plasmodium falciparum.The incubation period for the above mentioned speciesis 1 to 60 days depending on the type of parasite. High body temperature (fever), sweat, nausea, vomiting, dry cough and muscle ache are some of the common symptoms of malaria. Diagnosis technique for detection of malaria includesmicroscope using stained thin and thick peripheral blood smears (PBS), QBC technique, and serological tests. Various kinds of drugs are utilized as a treatment option for malaria that includes artemether-lumefantrine (Coartem), atovaquone-proguanil (Malarone), chloroquine, clindamycin (used in combination with quinine), doxycycline (used in combination with quinine), mefloquine (Lariam), quinidine and quinine. In 2014,WHO published that, around207 million caseswere recorded and approximately 627,000 deathsoccurred during the year 2012.
Request For Sample Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1972
Technological advancements in diagnostic tests and growing public awareness about the disease are the major factors driving the growth of malaria diagnostics market globally. However, technical complexities associated with existing diagnostic tests might hinder the market growth during the study period.
Geographically, RoW and Asia-Pacificdominates theglobal market for malariadiagnostics due to high prevalence rate and increased awareness among people about the disease. High death/fatality rate especially among young children is expected to propel the growth of this market in emerging economies of Asia-Pacific and Rest of the World (African countries).
Various key players contributing to the global malaria diagnostics market comprises Abbott Laboratories, Beckman Coulter/Danaher, bioMerieux, Bio-Rad Laboratories, Inc., Bio-Rad, Life Technology, Novartis Diagnostics, Ortho-Clinical Diagnostics, Siemens Healthcare and Wako Chemicals, Inc.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
Browse Full Report With TOC:-http://www.transparencymarketresearch.com/malaria-diagnostics-market.html
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
Albany NY - 12207